ライフサイエンスコーパス: gastrostomy

1 of aspiration after revision of her feeding gastrostomy.

2 considered a contraindication for radiologic gastrostomy.

3 centers accounted for nearly all feeding by gastrostomy.

4 d-state pressure transducer placed through a gastrostomy.

5 sac approach or the minilaparoscopic cystic gastrostomy.

6 d in December 2018, or had tracheostomies or gastrostomies.

7 butable to complicated appendicitis (18.4%), gastrostomy (13.4%), uncomplicated appendicitis (13.0%),

8 butable to complicated appendicitis (18.8%), gastrostomy (14.6%), fundoplication (10.4%), and uncompl

9 ), common bile duct exploration (24.9% MIS), gastrostomy (25.9% MIS), abdominal exploration (33.1% MI

10 were fed on demand, 54 by NG tube, and 10 by gastrostomy; 26 switched from NG to gastrostomy; and 6 r

11 Specifically, 3.5% had new gastrostomy, 3.1% new tracheostomy, 0.6% new vascular ac

12 1702402]), gastroschisis (9.5% [$34940331]), gastrostomy (5.8% [$21227436]), and small-intestinal atr

13 cluding 643 gastrojejunostomies (92%) and 58 gastrostomies (8.3%).

14 he need for research on the effectiveness of gastrostomy, access to non-invasive ventilation and pall

15 g the FMT group, 5 patients received FMT via gastrostomy alone, 4 via enema alone, and 1 with both ro

16 entions such as non-invasive ventilation and gastrostomy also extend survival.

17 zed: Only 9% undergo percutaneous endoscopic gastrostomy, although this procedure was recommended in

18 copically directed percutaneous placement of gastrostomy and gastrojejunostomy catheters with routine

19 Gastrostomy and jejunostomy can be successfully placed u

20 standing the advantages and disadvantages of gastrostomy and jejunostomy techniques.

21 ional involvement of a third region, needing gastrostomy and non-invasive ventilation.

22 perated using end-to-side hand-sewn esophago-gastrostomy and side-to-side stapled cervical esophagoga

23 l outcomes of hand-sewn end-to-side esophago-gastrostomy and side-to-side stapled cervical esophagoga

24 ion following the use of Foley catheter in a gastrostomy and the difficulties encountered in the surg

25 Five patients (10%) received gastrostomy and three (6%) non-invasive ventilation.

26 nally, obesity was associated with decreased gastrostomy and tracheostomy tube dependence compared wi

27 isease severities (patients with and without gastrostomy and tracheostomy tubes).

28 Of the 488 respondents, 84 with gastrostomy and/or tracheostomy tubes reported lower sco

29 drainage of proximal esophagus, percutaneous gastrostomy, and antibiotics.

30 nd 10 by gastrostomy; 26 switched from NG to gastrostomy; and 6 returned from NG to demand feeding.

31 olvement of third region; Stage 4A: need for gastrostomy; and Stage 4B: need for non-invasive ventila

32 Gastrostomies are frequently placed in older individuals

33 cal ventilation, hemodialysis, tracheostomy, gastrostomy, artificial nutrition, or cardiopulmonary re

34 gion at 38%, a third region at 61%, need for gastrostomy at 77% and need for non-invasive ventilation

35 echniques described, the authors prefer cyst gastrostomy by the lesser sac approach or the minilaparo

36 months) basis using a chronically implanted gastrostomy catheter and a flow-through swivel system.

37 A balloon and gastrostomy catheter were implanted into the stomach.

38 Placement of mushroom-retained gastrostomy catheters is a viable long-term treatment op

39 pacing, secretions, nutrition, dysphagia and gastrostomy, communication problems, mobility, spasticit

40 -like manner (two consecutive feedings), (2) gastrostomy control (GC) fed isocaloric milk formula via

41 urified from biofilms colonizing 18 silicone gastrostomy devices (12 "buttons" and six tubes converte

42 Percutaneous endoscopic gastrostomy feeding is well established, and follow-up s

43 associated positively with current eGFR and gastrostomy feeding prior to PD start.

44 ress, nonbilious vomiting and an ineffective gastrostomy feeding tube.

45 omy is indicated in the absence of dedicated gastrostomy feeding tubes; however, this approach has be

46 inability to walk, bradykinesia, scoliosis, gastrostomy feeding, age of seizure onset, and late age

47 The use of gastrostomy feeding, biocompatible dialysis fluid, and g

48 F patients receiving percutaneous endoscopic gastrostomy feeding.

49 f demand feeding and increased during NG and gastrostomy feeding.

50 n nasogastric, 19 on percutaneous endoscopic gastrostomy feeds) and entered into the study.

51 nts were respiratory failure (seven events), gastrostomy (five events), pneumonia (four events), and

52 Anesthetized rats had placement of a gastrostomy, followed 1 wk later by implantation of a ba

53 the age of 2 months, she had undergone Stamm gastrostomy for enteral feeding with a Pezzer catheter.

54 Gastrostomy, fundoplication, and appendectomy should be

55 duals received a feeding tube insertion (ie, gastrostomy, gastrostomy-jejunostomy, or jejunostomy tub

56 ylaxis undergoing endoscopy for percutaneous gastrostomy implantation.

57 is an independent prognostic factor; whether gastrostomy improves survival and quality of life remain

58 asis for recommending placement of a feeding gastrostomy in ALS patients who fail to meet their energ

59 for reduction of postpercutaneous endoscopic gastrostomy infections.

60 outine NIV users ALS patients, who underwent gastrostomy insertion for severe dysphagia and/or weight

61 Percutaneous endoscopic gastrostomy insertion may be possible without prior tran

62 In 1991, claims reflecting gastrostomy insertion were submitted for 81105 older Med

63 he diet, because TPN solution fed orally via gastrostomy instead of i.v. maintains NT anti-influenza

64 atheter as a replacement catheter in a Stamm gastrostomy is indicated in the absence of dedicated gas

65 on for patients when percutaneous endoscopic gastrostomy is not indicated because of anatomical or ga

66 d a feeding tube insertion (ie, gastrostomy, gastrostomy-jejunostomy, or jejunostomy tube), as identi

67 n fundoplication, appendectomy, splenectomy, gastrostomy/jejunostomy, orchidopexy, and cholecystectom

68 urgery, swallowing studies with percutaneous gastrostomy, mammography with breast biopsy and excision

69 ental feeding via a nasogastric (NG) tube or gastrostomy may improve growth, but this is not well und

70 Placement of a 14-F gastrostomy or gastrojejunostomy catheter was then accom

71 d for fluoroscopically directed percutaneous gastrostomy or gastrojejunostomy during a 9 1/2-year per

72 In 316 consecutive patients, radiologic gastrostomy or gastrojejunostomy with T-fastener gastrop

73 g neoadjuvant chemotherapy, developed bloody gastrostomy output and rapidly progressing nausea and ab

74 Percutaneous Endoscopic Gastrostomy (PEG) can involve some complications, despit

75 ry routinely receive percutaneous endoscopic gastrostomy (PEG) due to swallowing difficulty or lack o

76 at gastric juice and percutaneous endoscopic gastrostomy (PEG) feeding devices might yield MABSC isol

77 Percutaneous Endoscopic Gastrostomy (PEG) feeding tubes are frequently placed in

78 nce of living with a percutaneous endoscopic gastrostomy (PEG) in order to increase the understanding

79 he widespread use of percutaneous endoscopic gastrostomy (PEG) in pediatric populations, there is a p

80 Percutaneous endoscopic gastrostomy (PEG) is an effective and safe mode of enter

81 Percutaneous endoscopic gastrostomy (PEG) is the method of choice for patients i

82 ients were allocated percutaneous endoscopic gastrostomy (PEG) or nasogastric feeding.

83 Percutaneous Endoscopic Gastrostomy (PEG) tube insertion, a routine procedure fo

84 eral nutrition via a percutaneous endoscopic gastrostomy (PEG) tube is often part of management in pa

85 r pulling through of percutaneous endoscopic gastrostomy (PEG) tube through the esophagus).

86 for the placement of percutaneous endoscopic gastrostomy (PEG) tubes are not available.

87 gical ICU undergoing percutaneous endoscopic gastrostomy (PEG) were analyzed.

88 tracheostomy (BDT), percutaneous endoscopic gastrostomy (PEG), and inferior vena cava (IVC) filter p

89 body mass index < 20 kg/m(2) at the time of gastrostomy placement (HR 2.012, p = 0.016) and recurren

90 Gastrostomy placement can affect normal innate defense m

91 ne the prognostic factors for survival after gastrostomy placement in routine NIV users, taking into

92 r deceased from a hospital in 1991 following gastrostomy placement.

93 o cases of peritonitis, tract disruption, or gastrostomy-related death.

94 atients had an intraperitoneal leak from the gastrostomy requiring operative repair.

95 ts, while the management of appendicitis and gastrostomy should be considered high-priority condition

96 Time fed by gastrostomy significantly associated with higher lengths

97 chnique, and risk of percutaneous endoscopic gastrostomy site metastasis in head and neck cancer pati

98 use of mechanical ventilation, percutaneous gastrostomy, sociodemographic variables and a host of co

99 on rates similar to those reported for other gastrostomy techniques.

100 rs affecting survival and compared time from gastrostomy to death and 30-day mortality rate between d

101 Mean time from gastrostomy to death was significantly shorter in the de

102 n therapy involves endoscopic placement of a gastrostomy tube (A-Tube) and the AspireAssist siphon as

103 Gastrostomy tube (GT) placement is the most common gastr

104 l ventilation (IMV), percutaneous endoscopic gastrostomy tube (PEG), dialysis for acute kidney failur

105 hed wild type mice were fed via an implanted gastrostomy tube a high-fat diet for 9 weeks in the incr

106 One (2%) of 44 patients was dependent on a gastrostomy tube at 3 months and none was dependent 6 mo

107 require supplementation with nasogastric or gastrostomy tube at discharge from neonatal surgery.

108 2 was administered via a surgically inserted gastrostomy tube BID.

109 a (49% vs 31%), xerostomia (45% vs 33%), and gastrostomy tube dependence (40.2% vs 26.8%; p=0.018).

110 motor, fine motor, communication abilities, gastrostomy tube dependence and diagnosis of cortical vi

111 ad an increased risk of short- and long-term gastrostomy tube dependence and worse 5-year overall sur

112 I was also associated with decreased risk of gastrostomy tube dependence at 6 months (odds ratio [OR]

113 ding rate (-0.2% [95% CI, -5.6% to 5.3%]) or gastrostomy tube dependence rate (-0.5% [95% CI, -5.2% t

114 differences in oropharyngeal hemorrhage and gastrostomy tube dependence rates and 2-year and 5-year

115 mes (dysphagia, tracheostomy dependence, and gastrostomy tube dependence) were measured to 5 years af

116 years posttreatment and included dysphagia, gastrostomy tube dependence, and tracheostomy dependence

117 nts receiving surgery were less likely to be gastrostomy tube dependent at 6 months (OR, 0.46; 95% CI

118 Endoscopic or surgical insertion of a gastrostomy tube during a hospitalization.

119 discusses the complications associated with gastrostomy tube exchange and proposes a planned protoco

120 d proposes a planned protocol for successful gastrostomy tube exchange.

121 ube in the gastric lumen after a challenging gastrostomy tube exchange.

122 Supplemental nasogastric or gastrostomy tube feeding was carried out during the bloo

123 f 0.2 per month following the institution of gastrostomy tube feedings.

124 Use of supplemental gastrostomy tube feeds has improved calorie-protein maln

125 receiving IMPT had a percutaneous endoscopic gastrostomy tube for longer than 6 months.

126 replacement therapy, percutaneous endoscopic gastrostomy tube insertion, and tracheostomy) and in-hos

127 renteral nutrition (n = 11) through either a gastrostomy tube or a catheter placed in the jugular vei

128 ncluded poor functional level, presence of a gastrostomy tube or decubitus ulcers, and prior receipt

129 ormal saline with 9% glycerol) instilled via gastrostomy tube or enema without antibiotic or bowel pr

130 No patient required a gastrostomy tube or tracheotomy.

131 ere dosed at 12-hour intervals by means of a gastrostomy tube placed previously.

132 Gastrostomy tube placement (surgical or endoscopic) is a

133 resection, stenting, percutaneous endoscopic gastrostomy tube placement and photodynamic laser therap

134 nt studies involving percutaneous endoscopic gastrostomy tube placement have demonstrated equivalent

135 ey decision-making criteria when considering gastrostomy tube placement in NIV users ALS patients.

136 took to determine the safety and efficacy of gastrostomy tube placement in this population.

137 to maintain sufficient oral intake, feeding gastrostomy tube placement is required.

138 vs three [4%] in the isotonic saline group), gastrostomy tube placement or rupture (two [3%] vs one [

139 Gastrostomy tube placement was successful in 63 (98%) of

140 01), resulting in a higher rate of temporary gastrostomy tube placement, 46% v 20% (P <.01).

141 ivorship care needs, percutaneous endoscopic gastrostomy tube placement, nutrition literacy, psycholo

142 ition (specifically, tracheostomy placement, gastrostomy tube placement, vascular access devices, ost

143 r reintubation, and need for tracheostomy or gastrostomy tube placement.

144 ucosal resection, stenting, and percutaneous gastrostomy tube placements.

145 Percutaneous placement of a pull-type gastrostomy tube was performed with a minimum risk of tr

146 A gastrostomy tube was placed for daily aspiration of gast

147 Then the gastrostomy tube was pulled through from the mouth into

148 medical complications, and requirement for a gastrostomy tube were each independent predictors of neu

149 methoprim-sulfamethoxazole and presence of a gastrostomy tube were independent predictors of resistan

150 els of subgingival bacteria and yeasts in 20 gastrostomy tube-fed children and 24 healthy controls.

151 ating well or satisfactorily, and none had a gastrostomy tube.

152 gestion of a hand sanitizer product into his gastrostomy tube.

153 ecessitating nutritional supplementation via gastrostomy tube.

154 patients fed orally, and for patients fed by gastrostomy tube.

155 A gastropexy enables routine use of larger gastrostomy tubes and ready replacement of a displaced t

156 iratory disorders; and device use, including gastrostomy tubes and tracheostomies, was determined.

157 All patients who received pull-type gastrostomy tubes between 2010 and 2013 were retrospecti

158 ss for patients with percutaneous endoscopic gastrostomy tubes compared with those with nasogastric t

159 nasogastric tubes to percutaneous endoscopic gastrostomy tubes may be a successful strategy to reduce

160 udy of 10 LDS patients who had a total of 12 gastrostomy tubes placed.

161 20 mo; age range, 2-46 mo) fed orally or by gastrostomy tubes were evaluated.

162 tember 1995 through March 1997, 63 pull-type gastrostomy tubes were placed in 64 patients.

163 ulcers) and indwelling medical devices (eg, gastrostomy tubes) were detected as unique risk factors

164 idisciplinary teams, mechanical ventilation, gastrostomy tubes, lipid-lowering agents and symptom man

165 used more chronic technologies (ventilators, gastrostomy tubes, tracheostomy tubes, and parenteral nu

166 rough nasogastric or percutaneous endoscopic gastrostomy tubes, were included in this study.

167 vival with placement of new tracheostomy and gastrostomy tubes.

168 The hazard of death after gastrostomy was significantly affected by 3 factors: age

169 Cerebral angiogram, craniotomy, and gastrostomy were independently associated with absence o

170 istention or acid administration through the gastrostomy were recorded from the acromiotrapezius musc